Loading…

A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group

[Display omitted] Protein prenylation such as farnesylation and geranylgeranylation is associated with various diseases. Thus, many inhibitors of prenyltransferase have been developed. We report novel inhibitors of farnesyltransferase with a zinc-site recognition moiety and a farnesyl/dodecyl group....

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2017-08, Vol.27 (16), p.3862-3866
Main Authors: Tanaka, Ayumi, Radwan, Mohamed O., Hamasaki, Akiyuki, Ejima, Asumi, Obata, Emiko, Koga, Ryoko, Tateishi, Hiroshi, Okamoto, Yoshinari, Fujita, Mikako, Nakao, Mitsuyoshi, Umezawa, Kazuo, Tamanoi, Fuyuhiko, Otsuka, Masami
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] Protein prenylation such as farnesylation and geranylgeranylation is associated with various diseases. Thus, many inhibitors of prenyltransferase have been developed. We report novel inhibitors of farnesyltransferase with a zinc-site recognition moiety and a farnesyl/dodecyl group. Molecular docking analysis showed that both parts of the inhibitor fit well into the catalytic domain of farnesyltransferase. The synthesized inhibitors showed activity against farnesyltransferase in vitro and inhibited proliferation of the pancreatic cell line AsPC-1. Among the compounds with farnesyl and dodecyl groups, the inhibitor with a farnesyl group was found to have stronger and more selective activity.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2017.06.047